Igenica Biotherapeutics' Unattributed VC - III Round

Igenica Biotherapeutics raised a round of funding on October 14, 2015.

Igenica is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only biotherapeutic company that fully powers the ADC …

Articles about Igenica Biotherapeutics' Unattributed VC - III Round: